Atherectomy Devices Market Analysis

Atherectomy Devices Market Analysis

To get key market trends

  Download Free Sample

Orbital atherectomy devices industry generated USD 204 million in 2022 and is expected to witness robust growth through 2032. Orbital atherectomy devices are gaining significant traction owing to their several clinical benefits in minimally invasive procedures. These devices are designed to preserve the natural vessel anatomy while not damaging the healthy vessel walls. Their growing usage to assist in maintaining the integrity of the treated artery and reducing the risk of complications, such as vessel perforation or dissection will drive the market progression.
 

The atherectomy devices market from the ambulatory surgical centers segment is estimated to amass more than USD 404 million by 2032. Ambulatory surgical centers (ASCs) are increasingly preferred due to the high availability of comprehensive range of treatments and the growing adoption of advanced technology and equipment to cater to the patient population undergoing several diagnoses and treatments. Moreover, the improving reimbursement scenarios related to several surgeries in these facilities will propel the segment growth.
 

North America held the largest revenue share in the atherectomy devices industry and is expected to cross a valuation of USD 865 million by 2032. The growth can be ascribed to the presence of significant industry participants and the rising awareness of the advantages of precision atherectomy devices for both diagnosis and treatment. According to the CDC estimates, around 6.5 million people aged 40 and above were suffering from PAD in 2022. Moreover, the growing disease-prone population as well as the expanding elderly patient pool will drive regional market expansion.